We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New MRI Technique Reveals Hidden Heart Issues

By HospiMedica International staff writers
Posted on 05 Jun 2025

Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood return from the lower body. More...

This makes it difficult for physicians to distinguish between healthy individuals and those with heart disease, creating a diagnostic challenge in assessing true cardiac performance under stress. Researchers have now introduced a new technology: lower body negative-pressure pants that simulate upright posture, providing a more accurate picture of heart function during exercise.

The technology, developed at the University of Texas at Arlington (UTA, Arlington, TX, USA), is the outcome of research focusing on advancing noninvasive methods for exercise-based MRI testing. The patent-pending pants are among several innovations from the group aiming to transform how clinicians evaluate cardiovascular health. The negative-pressure pants function by creating a vacuum around the lower body, drawing blood downward and mimicking the effect of gravity when standing. This counteracts the misleading increase in stroke volume that occurs when lying flat, allowing physicians to observe cardiac performance under more realistic stress conditions. This innovation represents a major leap forward in cardiac imaging, improving the fidelity of exercise-based MRI tests.

Another advancement from the same team is a novel MRI technique to measure venous oxygen levels without the need for an invasive catheter. In a study published in the American Journal of Physiology, the researchers demonstrated that MRI can accurately assess how much oxygen is being extracted from the blood, eliminating the previous need to insert a catheter into the inferior vena cava. According to the researchers, the method offers the same precision as traditional procedures with significantly less risk to patients. Together, the ability to measure venous oxygenation and cardiac output during exercise enables clinicians to calculate whole-body oxygen usage—a vital marker for assessing risk of illness and death.

This integrated approach replaces the need for separate metabolic carts and oxygen masks with a fully MRI-based solution that is noninvasive and highly repeatable. These innovations are particularly valuable in understanding and treating exercise intolerance, a condition that not only signals underlying health problems but also significantly affects daily living. By identifying the physiological factors limiting exercise capacity, clinicians can develop more personalized and effective therapies.

“We’ve completely transformed the way we look at exercise cardiac MRI,” said researcher Michael Nelson, who led the team. “In my opinion, the recent developments we’ve made should become the new standard. You shouldn’t be doing exercise cardiac MRI without lower body negative-pressure pants.”

Related Links:
APAI Lab at University of Texas at Arlington 


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
12-Channel ECG
CM1200B
Fetal Monitor
BT-380
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.